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Tissue-speci®c T cell localization is crucial for
immune surveillance of normal tissues and the
pathogenesis of in¯ammatory disorders. In psoriatic
skin, CD8+ lymphocytes predominantly reside within
the epidermis, whereas CD4+ T cells are most
abundant within the dermis. Molecular mechanisms
guiding this spatial compartmentalization are not
completely understood, however. Here, we demon-
strate that 55% (69.7%, n = 14) of the epidermal T
cells, predominantly of the CD8+ phenotype,
expressed the integrin aE(CD103)b7. In contrast,
only 5% (62.0%) of the dermal T cells were
aE(CD103)b7+. Integrin aE(CD103)b7 was not
detected in normal skin (n = 10), and less than 1% of
peripheral blood lymphocytes derived from normal
(n = 11) or psoriatic (n = 10) donors expressed
aE(CD103). When cultured T lymphoblasts (n = 12
donors) were stimulated with transforming growth
factor b1, expression of integrin aE(CD103)b7 was
induced on 52.8% (616.2%) of CD8+ cells, but only
on 6.1% (62.3%) of CD4+ cells, suggesting selective
inducibility on CD8+ lymphocytes. Whereas similar
overall expression of transforming-growth-factor-b1-
speci®c mRNA was detected in normal and psoriatic
skin by real-time quantitative polymerase chain
reaction, immunohistochemistry revealed focal over-
expression of transforming growth factor b1 under-
neath psoriatic, but not normal, epidermis. This
heterogenous transforming growth factor b1 expres-
sion may contribute to induction of aE(CD103)
in vivo. Adhesion of transforming-growth-factor-b1-
stimulated CD8+, but not CD4+, T cells to cultured
keratinocytes and psoriatic epidermis in frozen sec-
tions could be signi®cantly inhibited by antibodies
that blocked the aE(CD103)/E±cadherin interaction.
Co-culture of lymphoblasts and keratinocytes
resulted in marginal enhancement of aE(CD103)b7
expression in some cases. Overall, integrin
aE(CD103)b7 appears to contribute to tissue-speci®c
epidermal localization of CD8+ T lymphocytes. Key
words: aEb7/CD103/CD8+ T cells/epidermotropism/
integrin/psoriasis/TGF-b1. J Invest Dermatol 117:569±
575, 2001
S
patial compartmentalization and tissue-speci®c localiz-
ation of T lymphocytes are essential requirements for
immune surveillance of normal skin and the pathogenesis
of in¯ammatory diseases. Subpopulations of T cells
localize to distinct cutaneous compartments, and the
pattern of T cell distribution may be characteristic for certain
disorders (Groves and Kupper, 1996). The tissue-speci®c localiz-
ation of T cells is guided by differential expression of cytokines and
chemokines and their receptors (Taub, 1996; SchoÈn and Ruzicka,
2001). In addition, a complex array of adhesion molecules
(Springer, 1994; Butcher and Picker, 1996) expressed by both T
cells and the resident cutaneous tissue is thought to mediate T cell
migration and retention (Nickoloff et al, 1990; Singer et al, 1990;
Picker et al, 1993, 1994). Thus, the functional analysis of adhesion
molecules, such as members of the integrin family (Hynes, 1992),
has shed light on key pathogenic events during the development of
in¯ammatory skin disorders (Singer et al, 1990). Members of the b1,
b2, and b7 subfamilies of integrins are expressed by T cells (Hemler,
1990; Springer, 1994). Among these, the b7 integrins, including
a4(CD49d)b7 and aE(CD103)b7, have a restricted expression
pattern (Wagner et al, 1996). Integrin a4(CD49d)b7 is involved in
T cell localization to organized lymphoid structures through
binding to Mad-CAM (Berlin et al, 1993; Rott et al, 1996). In
contrast, the aE(CD103)b7 integrin is expressed by more than 95%
of intestinal intraepithelial T lymphocytes, more than 40% of
lamina propria lymphocytes, and less than 2% of peripheral blood T
lymphocytes (PBL) (Cerf-Bensussan et al, 1987; Kilshaw and Baker,
1988; Parker et al, 1992), and is thought to contribute to
localization of diffusely distributed T cell subsets to the intestinal
epithelium (Kilshaw, 1999), presumably through binding to E-
cadherin (Cepek et al, 1994; Karecla et al, 1995, 1996; Higgins et al,
1998). Indeed, when integrin-aE(CD103)-de®cient mice were
studied, they exhibited a reduced number of mucosal intraepithelial
T cells (SchoÈn et al, 1999). There is growing evidence, however,
that the aE(CD103)b7 functions are not restricted to T cells within
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the intestinal mucosa, but also affect intraepithelial T cells in other
tissues whose epithelium expresses the ligand for aE(CD103)b7, E-
cadherin. In the skin, expression of aE(CD103)b7 has been shown
for epidermal T lymphocytes in some forms of in¯ammatory
disorders (de Vries et al, 1997; Walton et al, 1997) and cutanous T
cell lymphomas (Simonitsch et al, 1994; Dietz et al, 1996;
Schechner et al, 1999). A functional role of aEb7 for cutaneous T
cell localization and/or retention, however, has not been demon-
strated. In addition, mechanisms involved in regulation of
aE(CD103)b7 expression on epidermal T cells still remain
unknown. In vitro, transforming growth factor b1 (TGF-b1) can
maintain the aE(CD103)b7 phenotype on intestinal intraepithelial
T lymphocytes and induce expression of integrin aE(CD103)b7 on
PBL (Kilshaw and Murant, 1991; Parker et al, 1992; Cerwenka et al,
1994). It is currently not clear, however, whether TGF-b1
contributes to the induction of aE(CD103)b7 in vivo. To assess
whether aE(CD103)b7 is involved in tissue-speci®c localization of
cutaneous T cell subpopulations, we have studied its expression in a
common human skin disorder, psoriasis. In psoriatic lesions, CD8+
T cells localize preferentially to the epidermal compartment,
whereas CD4+ T cells predominantly reside within the dermis
(Hammar et al, 1984; Bos and de Rie, 1999). Here, we present data
demonstrating a preferential expression of aE(CD103)b7 on
epidermal CD8+ T cells within psoriatic lesions and show that
aE(CD103)b7 can be speci®cally upregulated by TGF-b1 on CD8+
T cells where it mediates adhesion to cultured keratinocytes as well
as to psoriatic epidermis. In addition, our data suggest that focal
upregulation of TGF-b1 in psoriatic skin might be involved in the
upregulation of aE(CD103)b7 in vivo. T cell contact to cultured
keratinocytes appears to play a limited, if any, role for induction of
aE(CD103)b7. Overall, our data suggest that the aE(CD103)b7
integrin is involved in tissue-speci®c epidermal localization of
CD8+ T cells in psoriasis and that microenvironmental factors may
induce its expression in vivo.
MATERIALS AND METHODS
Antibodies and secondary reagents Monoclonal antibodies (MoAb)
against human antigens were as follows: anti-CD3e (UCHT-1, Dako
Diagnostica, Hamburg, Germany), anti-CD4 (MT310, Dako), anti-
CD8a (DK25, Dako), anti-CD11a (SPV-L7, Zytomed, Berlin,
Germany), anti-CD30 (Ber-H8, Pharmingen, San Diego, CA), anti-
CD103 [Ber-Act8, Dako; aE7-1, aE7-2, aE7-3 (Russell et al, 1994),
gifts from M.B. Brenner, Brigham and Womens' Hospital, Boston, MA;
2G5, Immunotech Marseille, France], anti-cutaneous lymphocyte antigen
(anti-CLA) (HECA-452, Pharmingen), anti-E-cadherin [E4.6 (Cepek
et al, 1994), gift from M.B. Brenner], anti-gp80 (BT15, SchoÈn et al,
1995), anti-B-CAM (VF18, SchoÈn et al, 2000), and anti-TGF-b1 (TB21,
Serotech, Oxford, U.K.). Nonbinding isotype-matched MoAb were also
used as controls (mouse IgG1, MOPC 21, rat IgM, MOPC104E; Sigma,
Deisenhofen, Germany). For two-color ¯uorescence-activated cell sorter
(FACS) analysis, ¯uorochrome [¯uorescein isothiocyanate (FITC) or
R-phyroerythrin (RPE)] conjugates of the above MoAb were used. For
immunohistochemistry, biotinylated goat antimouse serum (Vector,
Burlingame, CA) was used as secondary reagent.
Isolation, culture, and stimulation of PBL PBL were isolated by
Ficoll-Paque gradient centrifugation (Pharmacia Biotech, Uppsala,
Sweden) from buffy coats or heparinized blood of adult donors, followed
by passage over nylon wool columns (Robbins Scienti®c, Sunnyvale,
CA) for T cell enrichment. The resulting populations were generally
more than 80% CD3+ as determined by FACS analysis. The
lymphocytes were then cultured in RPMI 1640 medium supplemented
with 10% fetal bovine serum (FBS; Biochrom, Berlin, Germany), 2 mM
L-glutamine, 100 U per ml penicillin, 100 U per ml streptomycin,
0.25 U per ml amphotericin B, 15 mM HEPES, 10 mM nonessential
amino acids (MEM), 10±5 M b-mercaptoethanol, 20 U per ml
interleukin-2 (all from Gibco BRL, Karlsruhe, Germany), and 0.5±1 mg
per ml phytohemagglutinin (PHA; Gibco BRL or Sigma). After 5±8 d of
culture, the populations were generally more than 90% CD3+ T cells.
Cultured PHA lymphoblasts were then stimulated with 2 ng per ml of
recombinant human TGF-b1 (Gibco BRL) for 5±14 d to induce
expression of the aE(CD103)b7 integrin (Kilshaw and Murant, 1991;
Parker et al, 1992). For isolation of CD4+ and CD8+ T cell
subpopulations, TGF-b1 stimulated PHA blasts were subjected to
negative selection by magnetic cell separation (MACS; Miltenyi,
Bergisch-Gladbach, Germany). The purity of the resulting cell
populations was generally greater than 96% as determined by FACS
analysis.
Keratinocyte culture Primary keratinocytes were prepared from
surgical specimens of normal human skin as described previously (SchoÈn
et al, 1995) and propagated in serum-free keratinocyte growth medium
(Gibco BRL) supplemented with 50 mg per ml bovine pituitary extract,
0.2 ng per ml epidermal growth factor (EGF), 2 mM L-glutamine, and
100 U per ml penicillin/streptomycin. The growth medium contained
low concentrations of Ca2+ (0.09 mM) to prevent keratinocyte
differentiation.
FACS analysis For FACS analysis, cells were washed twice with
phosphate-buffered saline (PBS) containing 0.5% bovine serum albumin
and 0.01% sodium azide (FACS buffer). Cells were then incubated with
the primary MoAb at 1 mg per 106 cells in 200 ml FACS buffer for 15±
20 min at 4°C. When unlabeled primary MoAb were used, cells were
washed three times with FACS buffer, incubated with FITC- or RPE-
coupled secondary reagents (DAKO) for 20 min at 4°C, and washed
again three times. After the staining procedure, cells were ®xed in 1%
paraformaldehyde. Cell surface ¯uorescence was analyzed using a
FACScan and the Cell Quest software (Becton Dickinson, Heidelberg,
Germany).
Immunohistochemistry Immunohistochemical studies were per-
formed on acetone-®xed serial cryostat-cut sections (5±7 mm) by the
ABC immunoperoxidase method (Vector). Brie¯y, sections were
incubated with 10% goat serum in PBS for 10 min followed by the
primary MoAb at 10 mg per ml for 30 min. After three washes in PBS,
endogenous peroxidase was blocked by 0.3% H2O2, and slides were
washed three times again. Sections were then incubated with the
secondary biotin-conjugated antibody (Vector) at 20 mg per ml for
30 min, washed three times again, and incubated with streptavidin-
horseradish-peroxidase complex (Dako). Bound MoAb was visualized
using 3-amino-9-ethyl-carbazole (Sigma) as chromagen. Sections were
counterstained with Gill's hematoxylin (Sigma) and LiCO3. For two-
color immunohistochemistry, the sections were incubated with the
unlabeled MoAb aE7-1 for 30 min at 4°C followed by FITC-
conjugated goat antimouse Ig (Vector). Thereafter, the slides were
washed three times and incubated with RPE-conjugated anti-CD8 or
anti-CD4 MoAb.
Real-time quantitative polymerase chain reaction (PCR)
(TaqMan) Biopsies from normal (n = 7 healthy volunteers; three
female, four male; median age 38.6 y) and lesional psoriatic skin (n = 24
patients with chronic plaque psoriasis untreated for at least 2 wk; 10
female, 14 male; median age 36.2 y) were homogenized in liquid
nitrogen using a Mikro-Dismembrator U (Braun Biotech, San Diego,
CA), and RNA was extracted with RNAzol according to the
manufacturer's protocol (Tel-Test, Friedensburg, TX). Four micrograms
of RNA were treated with DNAseI (Boehringer Mannheim, Mannheim,
Germany), and reverse transcribed using oligo-dT14-18 (Gibco BRL) and
random hexamer primers (Promega, Madison, WI). Fifty nanograms of
the resulting cDNA were ampli®ed in the presence of 12.5 ml of
TaqMan Universal Master Mix (Perkin Elmer, Foster City, CA),
0.625 ml of hTGF-b1-gene-speci®c TaqMan probe (Perkin Elmer),
0.5 ml of gene-speci®c forward and reverse primers (Perkin Elmer), and
0.5 ml of water. As an internal positive control, 0.125 ml of 18S
ribosomal RNA speci®c TaqMan probe (Perkin Elmer) and 0.125 ml of
18S ribosomal RNA speci®c forward and reverse primer (Perkin Elmer)
were added to each reaction. Gene-speci®c probes used FAM as reporter
whereas probes for the internal positive control were associated with the
VIC reporter. Samples underwent the following stages: (1) 50°C for 2
min; (2) 95°C for 10 min; and (3)±(43) 95°C for 15 s followed by 60°C
for 1 min. Gene-speci®c PCR products were measured by means of an
ABI Prism 7700 Sequence Detection System (Perkin Elmer)
continuously during 40 cycles. Target gene expression was normalized
between different samples based on the expression of the internal positive
control.
Radiolabeling of activated T lymphoblasts and static adhesion
assays Cultures of mixed lymphoblasts (>92% CD3+ cells), MACS-
enriched CD4+ T cells, or MACS-enriched CD8+ T cells (>96% pure)
were metabolically labeled with 35[S]-methionine (0.3 mCi per 107 cells)
for 8 h. After three washes in adhesion assay buffer (AAB; PBS
supplemented with 5% IgG-free FBS, 1 mM CaCl2, 2 mM MgCl2, and
15 mM HEPES), lymphoblasts were incubated with an anti-aE(CD103)
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MoAb (Ber-Act8), the nonbinding isotype-matched control MoAb, or
the surface-binding anti-CD30 MoAb (Ber-H8) at 2 mg per 106 cells for
15 min. Normal human keratinocytes in ®rst or second passage were
grown to a con¯uency of approximately 70% in 96-well microtiter plates
(Nunc, Roskilde, Denmark), rinsed twice with AAB, and incubated with
the anti-E-cadherin MoAb E4.6, the isotype-matched nonbinding
control MoAb, or the surface-binding anti-gp80 or anti-B-CAM MoAb
at 3 mg per well for 15 min. After two washes in AAB, T cells were
allowed to adhere to keratinocyte monolayers at 37°C for 45 min in a
humidi®ed incubator. Unbound cells were washed off in a standardized
fashion, and remaining cells were lyzed using a 2% sodium dodecyl
sulfate buffer. Bound radioactivity was quantitated with a liquid
scintillation counter (Packard, Groningen, The Netherlands).
Experiments were performed in sextuplicate.
Modi®ed Stamper±Woodruff assays Air-dried, cryostat-cut frozen
tissue sections of psoriatic human skin (n = 8 patients; three female, ®ve
male; median age 34.6 y; with chronic plaque psoriasis untreated for at
least 2 wk) were equilibrated with AAB. Prior to adhesion, the tissue
sections were incubated with the anti-E-cadherin MoAb (E4.6), the anti-
gp80 MoAb (BT15), or the nonbinding isotype-matched control MoAb
(MOPC 21), whereas mixed lymphoblasts, CD4+ T cells, and CD8+ T
cells were incubated with an anti-aE(CD103) MoAb (Ber-Act8), the
anti-CD30 MoAb (Ber-H8), or the nonbinding isotype-matched control
MoAb for 15 min, respectively. Sections were then overlayered with
lymphocytes at a density of 5 3 105 cells per section and incubated at
37°C and 5% CO2 for 45 min. Unbound cells were removed by gently
dipping the slides into PBS in a standardized fashion. Thereafter, sections
were ®xed in 4% paraformaldehyde for 10 min and stained with
hematoxylin. Lymphoblasts were quantitated microscopically as bound
cells per 0.5 mm epidermis in tissues from three different donors in each
experiment.
Co-culture experiments To assess the in¯uence of keratinocytes on
T cell expression of aE(CD103), human keratinocytes in ®rst or second
passage were cultured in 12-well culture dishes to an estimated
con¯uency of 70%. The culture supernatants were saved as conditioned
medium. Co-culture experiments with T lymphocytes were performed
as follows. (i) Keratinocyte monolayers were ®xed by ±20°C methanol
for 15 min, washed extensively with PBS, and equilibrated with culture
medium. Cultured or freshly isolated lymphoblasts were added at a
density of 2 3 106 cells per ml in either RPMI 1640 lymphoblast
growth medium supplemented with 3% FBS, conditioned medium
supplemented with 3% FBS, 15 mM HEPES buffer, 10 mM MEM,
20 U per ml interleukin-2, and 10±5 M b-mercaptoethanol, or a 1:1
mixture of both media. (ii) Cultured or freshly isolated lymphoblasts
were added to viable keratinocytes using the medium conditions
described above. For comparison, parallel cultures were established
without keratinocytes, in which the lymphoblasts were cultured in the
presence of PHA, EGF, Mg2+ and Ca2+, or TGF-b1 under otherwise
identical medium conditions. The proportion of aE(CD103)b7+/CD3+,
aE(CD103)b7+/CD4+, aE(CD103)b7+/CD8+ and CLA+/CD103+
lymphocytes was assessed by two-color FACS analysis after 0 d, 3±5 d
and 7±8 d.
Statistical analysis Data were presented as means 6 SD. Statistical
signi®cance was assessed by a two-tailed Student's t test, and p < 0.05
was considered signi®cant.
RESULTS
Integrin aE(CD103) is preferentially expressed on epidermal
CD8+ T cells in psoriatic skin When the phenotype of T
lymphocytes was assessed by immunohistochemistry in psoriatic
lesions (n = 14), prominent expression of integrin aE(CD103)b7
was found on T cells within all viable layers of the epidermis
(Fig 1A). Based upon quantitation of T cells in sequential cryostat-
cut sections, 55.0% (69.7%) of epidermal CD3+ T cells but only
5.7% (62.0%) of dermal T cells expressed aE(CD103). In contrast,
T cells were very rarely seen in the epidermis of normal skin (three
out of 10 biopsies with one or two epidermal T cells).
To further characterize the T cell subset expressing the
aE(CD103)b7 integrin, two-color immuno¯uorescent stainings
were performed on cryostat-cut sections of psoriatic skin (n = 5). It
was found that aE(CD103)b7 was primarily expressed by CD8+ T
cells whereas only few cells were of the CD4+/CD103+ phenotype
(Fig 1B). This observation is consistent with the preferential
epidermal localization of CD8+ T cells in psoriatic lesions (Hammar
et al, 1984; Bos and de Rie, 1999) and the proposed association of
aE(CD103) with T cells of the CD8 lineage (Kilshaw and Murant,
1990; Lefrancois et al, 1994). As the ligand for aE(CD103)b7, E-
cadherin, is expressed throughout the viable epidermal cell layers
(Furukawa et al, 1994), the expression of aE(CD103)b7 by
epidermal CD8+ T cells suggested a role of this adhesion receptor
for tissue-speci®c epidermal localization or retention of CD8+ T
cells. Few dermal CD8+ T cells also expressed aE(CD103)b7
(estimated 5%±10% based upon two-color immuno¯uorescence).
Given the prominent expression of aE(CD103)b7 in psoriatic
but not normal skin, we assessed its expression on freshly isolated T
cells of the peripheral blood (PBL) from healthy volunteers
(n = 12) and psoriasis patients (n = 9). As expected (Rott et al,
1996), FACS analysis revealed expression of aE(CD103) on 0.86%
(60.26%) of CD3+ PBL from normal donors. Interestingly, there
was no increase in aE(CD103)b7 expression on PBL isolated from
Figure 1. Integrin aE(CD103)b7 is preferentially expressed by
CD8+ epidermal T cells in psoriatic skin. (A) Sequential cryostat-cut
sections of psoriatic skin were stained by the ABC immunoperoxidase
method using anti-CD3 (left panel) and anti-aE(CD103) MoAb. The
panels depicted are representative for tissues from 14 psoriasis patients.
Scale bar: 20 mm. (B) Sequential frozen sections of psoriatic skin were
subjected to two-color immuno¯uorescence staining using an FITC-
conjugated anti-aE(CD103) MoAb (green ¯uorescent signals), followed
by PE-conjugated anti-CD4 (red signals) or PE-conjugated anti-CD8a
(red signals) as indicated. Pictures were taken from the same microscopic
®elds using an FITC and a PE ®lter. The photomicrographs shown here
are representative of tissue specimens from ®ve different patients. Scale
bar: 20 mm.
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psoriasis patients (0.51%; SD 60.18%). This observation is con-
sistent with the hypothesis that integrin aE(CD103)b7 expression is
induced in situ in psoriatic lesions.
Integrin aE(CD103)b7 is selectively induced on CD8+ T cells
in vitro In vitro, the expression of integrin aE(CD103)b7 on PBL
can be induced by TGF-b1 (Kilshaw and Murant, 1991; Cepek et
al, 1993; Russell et al, 1994) or, as reported in one study, by culture
with PHA and interleukin-2 (Brew et al, 1995). In this study,
experiments were performed with lymphoblasts from more than 30
different blood donors. Culture in the presence of PHA and
interleukin-2 alone resulted in the induction of aE(CD103)b7
expression by up to 10% of cultured T cells from six donors. This
phenotype, however, was observed only in the ®rst week of culture
and was not maintained during long-term culture (data not shown).
In contrast, aE(CD103)b7 expression on T lymphoblasts was
strongly upregulated and maintained by incubation of PHA-
activated T lymphocytes with 2 ng per ml TGF-b1. Interestingly,
two-color FACS analyses (n = 12 donors) revealed that 52.8%
(6 16.2%) of the CD8+ T cells but only 6.1% (6 2.3%) of CD4+
T cells expressed integrin aE(CD103)b7 (Fig 2). Maximum
expression of aE(CD103) was seen after 5±14 d of TGF-b1
treatment, suggesting interindividual differences in the TGF-b1
responsiveness of T lymphocytes (Fig 2). PBL isolated from
psoriasis patients (n = 7 donors) were similarly responsive to
TGF-b1 (CD8+/CD103+ 40.5% 6 8.8% vs CD4+/CD103+
7.6% 6 4.6%).
Given that TGF-b1 has been reported to upregulate expression
of CLA, which is thought to act as a skin-speci®c homing receptor
of T cells (mostly CD4+) (Picker et al, 1991), we assessed whether
aE(CD103) and CLA might be coexpressed by some T cells. CLA
was expressed by 8.2% (63.1%) of freshly isolated PBL from
psoriasis patients (n = 8) and by 8.0% (63.4%) of PBL from healthy
donors (n = 9), suggesting that there are no signi®cant differences
in CLA expression between normal and psoriatic individuals in vivo.
As expected (Picker et al, 1994), CLA was primarily expressed by
CD4+ T cells. As assessed by two-color FACS analysis, only 0.3%
(60.1%, n = 9) of PBL from healthy donors and 0.2% (60.1%) of
PBL from psoriasis donors (n = 8) coexpressed integrin aE(CD103)
and CLA.
In contrast to the strong in vitro induction of aE(CD103)b7, only
6.5% (62.7%) of T lymphoblasts from psoriasis patients (n = 4) and
8.5% (64.6%) of T lymphoblasts from healthy donors (n = 9)
expressed CLA when cultured in the presence of 2 ng per ml TGF-
b1 for 14 d. In addition, as assessed by two-color FACS analysis,
TGF-b1 did not signi®cantly increase the proportion of T
lymphoblasts coexpressing aE(CD103)b7 and CLA [1.08%
(60.39%) for psoriatic donors (n = 4) versus 0.67% (60.8%) for
healthy donors (n = 9)], suggesting that expression of aE(CD103)
and of CLA on T cells are regulated differentially.
Integrin aE(CD103)b7 mediates adhesion of activated CD8+
T cells, but not CD4+ T cells, to cultured human
keratinocytes In order to assess the functional relevance of
aE(CD103)b7, PHA-, and TGF-b1- stimulated, unfractionated T
lymphoblasts (>90% CD3+), the CD3+/CD4+ subset (>98% pure)
and the CD3+/CD8+ subset (>96% pure) were metabolically
labeled with 35[S]-methionine and allowed to adhere to a matrix of
cultured normal human keratinocytes. Based upon quantitation of
bound radioactivity in three independent experiments, all three
lymphoblast populations strongly adhered to the monolayer of
cultured keratinocytes. In a representative experiment performed in
sextuplicate, blocking of integrin aE(CD103) by MoAb Ber-Act8
reduced the binding of mixed T lymphoblasts [aE(CD103)+/CD8+
39.55%] by 42.7% [63.4%, p = 0.0005 comparing adhesion of T
cells after incubation with isotype control MoAb and anti-
aE(CD103)], and the adhesion of the CD8+ T cells subset by
25.9% (64.2%, p = 0.01) (Fig 3A). Similarly, the anti-E-cadherin
MoAb, E4.6, reduced binding of mixed lymphocytes by 35.4%
(65.1%, p = 0.002) and binding of the CD3+/CD8+
subpopulation by 17.1% (611%, p = 0.01), compared to the
isotype-treated controls. When both aE(CD103) and E-cadherin-
speci®c MoAb were used, adhesion of mixed lymphoblasts was
reduced by 43.42% (61.34%, p = 0.0003) and adhesion of the
CD8+ subset was reduced by 28.9% (67.9%, p = 0.002 compared
to isotype controls). In contrast, adhesion of CD4+ T cells was not
affected signi®cantly by either anti-aE(CD103) or anti-E-cadherin
(Fig 3A). These results were con®rmed in two independently
performed subsequent experiments showing similar results. As the
surface-binding control MoAb, BT15, VF18, or Ber-H8, did not
signi®cantly affect T cell binding to cultured keratinocytes (data not
shown), the inhibition of binding by both anti-aE- and anti-E-
cadherin MoAb was not due to unspeci®c effects following surface
binding of MoAb. Of note, the relative inhibition of cellular
adhesion appeared to correlate with the proportion of aE(CD103)+
cells in the cultures. These results suggested that aE(CD103) is
important for adhesive interactions of CD8+ T cells and
keratinocytes. More than 90% of TGF-b1-stimulated T lympho-
blasts expressed LFA-1, however, and incubation with anti-LFA-1
MoAb almost completely (84% in one experiment and 91% in a
con®rmatory experiment) inhibited binding of these cells to
cultured keratinocytes. MoAb speci®c for aE(CD103) did not
signi®cantly increase this effect.
Integrin aE(CD103)b7 mediates adhesion of CD8+ T cells to
psoriatic epidermis To directly assess the role of aE(CD103)b7
in adhesive interactions between T lymphocytes and psoriatic
epidermis, modi®ed Stamper±Woodruff assays were performed. In
these experiments, TGF-b1-stimulated unfractionated lymphoblasts
(>90% CD3+), CD8+ T cells (>96% CD3+/CD8+), or CD4+ T
Figure 2. Integrin aEb7 can be selectively induced on activated
CD8+ T lymphocytes by TGF-b1 in vitro. PBL were cultured in the
presence of PHA (0,5 mg per ml) and interleukin-2 (20 U per ml) for
10 d. Thereafter, TGF-b1 (2 ng per ml, right panels) or control medium
(left panels) was added for 14 d, and the cells were subjected to two-color
FACS analysis as outlined in Materials and Methods. The subset
distribution was assessed by staining with CD4-RPE/CD103-FITC
(upper row) or CD8-RPE/CD103-FITC (lower row), respectively.
Double-positive cells are located in the upper right quadrant (0.2% in
upper left panel; 1.8% in lower left panel; 4.9% in upper right panel; 48.7% in
lower right panel).
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cells (>98% CD3+ n = 5 blood donors in each case) were allowed
to adhere to un®xed cryostat-cut frozen sections of psoriatic skin
(n = 8 donors). All T lymphocyte populations examined adhered
well to the epidermal compartment of the skin. In a representative
experiment with T lymphoblasts expressing aE(CD103) on 41.6%
of CD8+ T cells, MoAb Ber-Act8 reduced the adhesion of
unfractionated lymphoblasts signi®cantly by 26.5% (618.0%,
p < 0.0001 compared to the isotype-matched control), and
adhesion of the CD8+ enriched population was inhibited by
47.7% (617.3%, p < 0.0001 comparing binding inhibition of
CD8+ and isotype control MoAb) (Fig 3B). Likewise,
preincubation of the skin sections with the E-cadherin-speci®c
MoAb E4.6 reduced the epidermal binding of unfractionated T
cells by 36.7% (68.2%, p < 0.0001) and binding of puri®ed CD8+
T cells by 32.6% (610.4%, p < 0.0001). Simultanous incubation
with both MoAb did not increase the inhibitory effect
(unfractionated lymphoblasts, 35.4% 6 9.8%, p < 0.0001; CD8+
T cells, 11.19% 6 1.2%, p < 0.0001, compared to the isotype
control). Epidermal adhesion of TGF-b1-stimulated CD4+ T cells,
however, was not negatively affected by either MoAb (Fig 3B).
Incubation with the surface-binding MoAb, BT15, VF18, or Ber-
H8, did not signi®cantly affect epidermal T cell binding (not
shown). In addition, T lymphoblast binding to dermal components
was not affected by either anti-aE(CD103) or anti-E-cadherin
MoAb (data not shown). Similar results were obtained in three
independent experiments strongly suggesting a role of both
aE(CD103) and E-cadherin in adhesive interactions of some
CD8+ T cells and the psoriatic epidermis.
Focal overexpression of TGF-b1 in psoriatic skin How is
aE(CD103)b7 induced on T lymphocytes localizing to the
epidermis? To approach this as yet unanswered question, we
assessed expression of TGF-b1 in psoriatic and normal skin to
estimate its potential role for the induction of aE(CD103)b7 in vivo.
Thus far, TGF-b1 is the only known stimulator for integrin
aE(CD103)b7 expression on T lymphocytes (Kilshaw and Murant,
1991; Cepek et al, 1993). Real-time PCR (TaqMan) was
performed to quantitatively assess TGF-b1 mRNA expression in
normal (n = 7) and psoriatic (n = 24) skin. Both groups showed
considerable interindividual variation, but the average expression of
TGF-b1 mRNA was not signi®cantly different [159 fg per 100 ng
cDNA (657.4) in normal versus 133 fg per 100 ng cDNA (672.3)
in psoriatic skin] (Fig 4A). These results suggested that the
induction of aE(CD103)b7 on epidermal T cells within psoriatic
lesions was not due to a general increase of TGF-b1 expression.
Interestingly, however, immunohistochemical analysis revealed a
marked focal expression of total TGF-b1 in psoriatic skin in some
dermal papillae directly underneath the hyperplastic epidermis. This
was not seen in normal skin (Fig 4B). To assess the potential
colocalization of aE(CD103)b7-expressing T cells and TGF-b1,
immunohistochemical studies were performed using sequential
sections of psoriatic tissue (n = 7). As TGF-b1 was located in the
dermis, however, and aE(CD103)b7-expressing cells resided within
the epidermis, a clear-cut demonstration of such a colocalization
was not possible. Overall, it is conceivable that focal overexpression
of TGF-b1 contributes to the induction of aE(CD103)b7 on T
lymphocytes approaching the epidermis within the psoriatic
microenvironment.
A limited role of T cell±keratinocyte interactions for
induction of aE(CD103)b7 As aE(CD103) expression was
almost exclusively seen on intraepidermal T cells in psoriatic
epidermis, we sought to approach the question whether epidermis-
associated factors might contribute to aE(CD103) expression by T
lymphocytes. To assess such putative additional factors,
unfractionated T lymphoblasts were co-cultured with epidermal
keratinocytes under various conditions as outlined in Materials and
Methods. In four initial experiments, it appeared that co-culture of
PHA blasts with viable keratinocytes induced aE(CD103)
expression marginally on approximately 5% of T cells,
superimposing on the induction achieved by TGF-b1. We
therefore examined several conditions including co-culture with
®xed keratinocytes, co-culture with or without keratinocyte-
conditioned medium, co-culture in the presence of TGF-b1-
neutralizing MoAb, and combinations of these conditions. It was
found that the additional induction of aE(CD103) by cultured
normal keratinocytes under the conditions tested was not consistent
and appeared to have considerable interindividual variations (data
not shown). These experiments do not formally rule out the
possibility, however, that keratinocytes contribute to aE(CD103)
expression in vivo.
Figure 3. Integrin aE(CD103)b7 and E-cadherin mediate binding
of activated CD8+ T lymphoblasts to cultured keratinocytes and
to psoriatic epidermis. (A) After stimulation with 2 ng per ml TGF-
b1 for 14 d, unfractionated lymphocytes (>90% CD3+, left panel),
puri®ed CD3+/CD8+ (>96% pure, middle panel), or puri®ed CD3+/
CD4+ (>98% pure, right panel) lymphoblasts were radiolabeled with
35[S]-methionine. Thereafter, T lymphoblasts were overlayered onto
subcon¯uent cultures of human keratinocytes in 96-well plates. For
antibody-mediated blocking, the T lymphoblasts and keratinocytes were
incubated with isotype-matched control MoAb (left columns), anti-
aE(CD103) MoAb (second from left), anti-E-cadherin MoAb (third
from left), or a combination of anti-aE- and anti-E-cadherin MoAb (right
columns). The lymphoblasts then adhered for 45 min in the presence of
1 mM CaCl2 and 2 mM MgCl2. Bound cells were lyzed in a 2% sodium
dodecyl sulfate buffer, and bound radioactivity was quantitated. Bars
represent the means (6SD) of sextuplicates. *p < 0.05; **p < 0.01
comparing adhesion after MoAb treatment with isotype controls. The
experiment shown is representative for three independent experiments
showing similar results. (B) T lymphoblasts were separated and labeled as
outlined above. Cryostat-cut frozen sections of psoriatic skin were
rehydrated in AAB containing 1 mM CaCl2 and 2 mM MgCl2 and, after
incubation with isotype control MoAb (left columns), anti-aE(CD103)
MoAb (second from left), anti-E-cadherin MoAb (third from left), or a
combination of anti-aE(CD103) and anti-E-cadherin MoAb (right
columns), overlayered with T lymphoblasts for 45 min as described in (A).
Bound cells were quantitated per millimeter DEJ in at least 16
microscopic ®elds. Bars represent mean values (6SD), **p < 0.01
comparing adhesion of MoAb-treated samples and isotype controls. The
experiment shown is representative for eight different psoriatic tissues
and ®ve different blood donors.
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DISCUSSION
Given the importance of selective therapies, molecular mechanisms
guiding tissue-speci®c compartmentalization of T cells in in¯am-
matory disorders are a major research focus. We have identi®ed the
integrin aE(CD103)b7 as a receptor mediating adhesive interactions
between CD8+ T lymphocytes and epidermal keratinocytes, thus
presumably contributing to epidermal localization and/or retention
of a speci®c T cell subset. The ®rst steps of T cell localization,
including rolling, ®rm adhesion, extravasation, and transmigration
through connective tissues, are relatively well understood (Groves
and Kupper, 1996). Leukocyte rolling on the vessel wall is
mediated primarily by selectins, including P-, E-, and L-selectin
(Groves et al, 1991; Smith et al, 1993). Glycoproteins bearing the
Sialyl-LewisX. moiety function as E-selectin ligands (Varki, 1994),
including CLA, which is thought to be involved in tissue-speci®c
localization of cutaneous T cells (Picker et al, 1991). Rolling
leukocytes then ®rmly attach and transmigrate using b2- and b1-
integrins (Dustin et al, 1986; Hemler, 1990; Hynes, 1992), and
CD44, a hyaluronate receptor (Camp et al, 1993).
In contrast to endothelial and dermal localization, we know little
about epidermal localization of T cells. Many ligands for T cell
adhesion receptors, such as b1-integrin ligands, are not expressed
beyond the epidermal basement membrane (Konter et al, 1989).
Induced by proin¯ammatory cytokines, there is de novo expression
of intercellular adhesion molecule 1 (ICAM-1) in in¯amed
epidermis (Dustin et al, 1988; Grif®ths et al, 1989). Indeed, in vitro
studies suggested that ICAM-1±LFA-1 interactions mediate bind-
ing of activated T cells to in¯amed epidermis (Kashihara-Sawami
and Norris, 1992). This may not be the only mechanism, however,
as constitutive epidermal expression of ICAM-1 in transgenic mice
did not result in cutaneous T cell in®ltration (Williams and Kupper,
1994), and expression and spatial distribution of ICAM-1 and
LFA-1 do not correlate in many cases (Grif®ths et al, 1989; Konter
et al, 1989; Olivry et al, 1995). The recently identi®ed glycoprotein
LEEP-CAM (lymphocyte endothelial±epithelial cell adhesion
molecule), whose ligand on T has not been identi®ed yet, may
also be involved in epidermal T cell localization (Shieh et al, 1999).
Overall, molecular mechanisms guiding epidermal localization of T
lymphocytes still remain somewhat obscure. In this setting, the
integrin aE(CD103)b7 is an interesting candidate molecule mediat-
ing epidermal localization of a particular T cell subset, namely
CD8+ T cells, possibly complementing other mechanisms. As
epidermal CD8+ T cells are thought to play a pathogenic role in
common in¯ammatory skin disorders, such as psoriasis (Hammar
et al, 1984; Bos and de Rie, 1999; Prinz, 1999), it is conceivable
that compounds interfering with the aE(CD103)b7 function may
speci®cally alleviate such disorders. Indeed, expression of
aE(CD103)b7 has been described in several in¯ammatory skin
conditions, such as lichen planus and atopic dermatitis (de Vries et
al, 1997; Walton et al, 1997), as well as in some cutaneous T cell
lymphomas (Simonitsch et al, 1994; Dietz et al, 1996; Schechner
et al, 1999). CLA and integrin aE(CD103)b7 may not act
synergistically on a given T cell subset, as these adhesion receptors
were not coexpressed by most T cells in our experiments.
Expression of aE(CD103)b7 was detected on very few dermal T
cells in psoriatic lesions as well as in the peripheral blood, which is
consistent with previous reports (Cerf-Bensussan et al, 1987; Parker
et al, 1992). Thus, aE(CD103)b7 appears to be induced on CD8+ T
cells in situ upon entering the epidermis, consistent with the focal
expression of TGF-b1 directly underneath the epidermis. There is
no experimental proof thus far, however, directly demonstrating
such a role of TGF-b1 in vivo. Although direct interactions of T
cells and keratinocytes resulted only in marginal induction of
aE(CD103)b7 on some T cells in vitro, it cannot be formally ruled
out that such mechanisms or other keratinocyte-derived factors
may contribute to aE induction in vivo. In addition, it is possible
that aE(CD103)b7 also mediates adhesion to other as yet
unidenti®ed ligands within the epidermis, as one recent study
suggested an alternative ligand for aE(CD103)b7 within the
epidermis (Brown et al, 1999). Given that the aE(CD103)b7
ligand, E-cadherin, is constitutively expressed throughout all viable
layers of the epidermis (Furukawa et al, 1994), it is possible that the
aE(CD103)b7±E-cadherin interaction is regulated via alternate
functional states of E-cadherin (Higgins et al, 1998) and/or on the
level of aE(CD103)b7 itself. In any case, based upon our
observation that TGF-b1 is focally upregulated within psoriatic
skin, it is possible that this heterogenous expression contributes to
site-speci®c induction and function of aE(CD103)b7 in the
cutaneous microenvironment in vivo, similar to the intestinal
mucosal microenvironment (Kilshaw, 1999). Consistent with
previous circumstantial evidence that aE(CD103) expression is
associated with T cells of the CD8+ lineage (Kilshaw and Murant,
1990; Lefrancois et al, 1994), our experiments demonstrated a
selective inducibility of aE(CD103)b7 on CD8+ T cells. This
mechanism may, at least in part, contribute to the spatial
compartmentalization of T cells in psoriasis. Expression of
aE(CD103)b7 may explain (at least in part) adhesion but not
necessarily directed migration of this T cell subset to the epidermis.
The aE(CD103)-related action of TGF-b1 on epidermis-entering
T cells may be 2-fold: on the one hand, TGF-b1 might modulate
the preferential association of the aE and b7 subunits by down-
regulating a4(CD49d)b7 (Lim et al, 1998); on the other hand,
TGF-b1-responsive elements have been identi®ed in the 5¢
proximal promoter regions of both the b7 and aE encoding gene
regions (Lim et al, 1998).
Figure 4. TGF-b1 is focally overexpressed in psoriatic skin,
whereas total amounts of TGF-b1 mRNA are similar in psoriatic
and normal skin. (A) Total RNA was extracted from skin biopsies
obtained from psoriatic lesions (n = 24) and normal skin (n = 7), reverse
transcribed, and analyzed using quantitative real time PCR (TaqManâ).
The data were normalized against the internal control and presented as fg
TGF-b1-speci®c probe per 100 ng cDNA. (B) Frozen sections of normal
(left panel) and psoriatic (right panel) skin were stained by the ABC
immunoperoxidase method using a TGF-b1-speci®c MoAb. Positive
signals are visualized by the red color. Scale bar: 20 mm. The
photomicrographs shown are representative of six different tissue
specimens each from normal and psoriatic skin.
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